Bank of New York Mellon’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.74B | Sell |
4,783,459
-76,949
| -2% | -$78.6M | 0.94% | 14 |
|
|
2026
Q1 | $4.47B | Sell |
4,860,408
-224,084
| -4% | -$227M | 0.82% | 15 |
|
|
2025
Q4 | $5.46B | Sell |
5,084,492
-15,660
| -0.3% | -$15M | 0.96% | 14 |
|
|
2025
Q3 | $3.89B | Sell |
5,100,152
-100,563
| -2% | -$74.8M | 0.7% | 17 |
|
|
2025
Q2 | $4.05B | Sell |
5,200,715
-384,456
| -7% | -$299M | 0.77% | 16 |
|
|
2025
Q1 | $4.61B | Sell |
5,585,171
-279,215
| -5% | -$232M | 0.91% | 15 |
|
|
2024
Q4 | $4.53B | Sell |
5,864,386
-117,551
| -2% | -$97.3M | 0.84% | 15 |
|
|
2024
Q3 | $5.3B | Sell |
5,981,937
-602,348
| -9% | -$542M | 0.99% | 12 |
|
|
2024
Q2 | $5.96B | Sell |
6,584,285
-188,413
| -3% | -$151M | 1.13% | 10 |
|
|
2024
Q1 | $5.27B | Sell |
6,772,698
-616,256
| -8% | -$439M | 1.01% | 11 |
|
|
2023
Q4 | $4.31B | Sell |
7,388,954
-470,870
| -6% | -$275M | 0.87% | 15 |
|
|
2023
Q3 | $4.22B | Sell |
7,859,824
-579,799
| -7% | -$299M | 0.93% | 14 |
|
|
2023
Q2 | $3.96B | Sell |
8,439,623
-539,982
| -6% | -$226M | 0.83% | 14 |
|
|
2023
Q1 | $3.08B | Sell |
8,979,605
-142,851
| -2% | -$48.2M | 0.67% | 20 |
|
|
2022
Q4 | $3.34B | Sell |
9,122,456
-467,900
| -5% | -$166M | 0.76% | 16 |
|
|
2022
Q3 | $3.1B | Sell |
9,590,356
-135,532
| -1% | -$42.9M | 0.75% | 13 |
|
|
2022
Q2 | $3.15B | Buy |
9,725,888
+486,011
| +5% | +$146M | 0.72% | 16 |
|
|
2022
Q1 | $2.65B | Sell |
9,239,877
-25,615
| -0.3% | -$6.59M | 0.51% | 30 |
|
|
2021
Q4 | $2.56B | Buy |
9,265,492
+127,286
| +1% | +$32.3M | 0.46% | 39 |
|
|
2021
Q3 | $2.11B | Sell |
9,138,206
-412,682
| -4% | -$102M | 0.41% | 47 |
|
|
2021
Q2 | $2.19B | Sell |
9,550,888
-236,938
| -2% | -$47.6M | 0.42% | 43 |
|
|
2021
Q1 | $1.83B | Buy |
9,787,826
+505,780
| +5% | +$98.9M | 0.37% | 53 |
|
|
2020
Q4 | $1.57B | Sell |
9,282,046
-279,578
| -3% | -$41.7M | 0.34% | 64 |
|
|
2020
Q3 | $1.42B | Buy |
9,561,624
+516,719
| +6% | +$80M | 0.35% | 64 |
|
|
2020
Q2 | $1.48B | Buy |
9,044,905
+629,683
| +7% | +$96.7M | 0.4% | 51 |
|
|
2020
Q1 | $1.17B | Buy |
8,415,222
+289,291
| +4% | +$39.7M | 0.39% | 58 |
|
|
2019
Q4 | $1.07B | Buy |
8,125,931
+111,832
| +1% | +$13M | 0.28% | 78 |
|
|
2019
Q3 | $896M | Buy |
8,014,099
+84,398
| +1% | +$9.4M | 0.25% | 81 |
|
|
2019
Q2 | $879M | Sell |
7,929,701
-223,459
| -3% | -$26.3M | 0.24% | 85 |
|
|
2019
Q1 | $1.06B | Sell |
8,153,160
-1,022,732
| -11% | -$124M | 0.3% | 71 |
|
|
2018
Q4 | $1.06B | Sell |
9,175,892
-325,250
| -3% | -$36.3M | 0.33% | 62 |
|
|
2018
Q3 | $1.02B | Buy |
9,501,142
+27,009
| +0.3% | +$2.7M | 0.26% | 72 |
|
|
2018
Q2 | $808M | Sell |
9,474,133
-559,789
| -6% | -$46M | 0.22% | 84 |
|
|
2018
Q1 | $776M | Sell |
10,033,922
-95,112
| -0.9% | -$7.66M | 0.21% | 85 |
|
|
2017
Q4 | $855M | Sell |
10,129,034
-1,180,502
| -10% | -$100M | 0.23% | 82 |
|
|
2017
Q3 | $967M | Sell |
11,309,536
-2,318,983
| -17% | -$190M | 0.27% | 74 |
|
|
2017
Q2 | $1.12B | Sell |
13,628,519
-1,101,199
| -7% | -$89.8M | 0.32% | 65 |
|
|
2017
Q1 | $1.24B | Sell |
14,729,718
-850,240
| -5% | -$68.1M | 0.34% | 58 |
|
|
2016
Q4 | $1.15B | Buy |
15,579,958
+415,743
| +3% | +$31M | 0.33% | 62 |
|
|
2016
Q3 | $1.22B | Buy |
15,164,215
+984,404
| +7% | +$78.8M | 0.36% | 56 |
|
|
2016
Q2 | $1.12B | Sell |
14,179,811
-319,379
| -2% | -$24M | 0.34% | 65 |
|
|
2016
Q1 | $1.04B | Buy |
14,499,190
+437,458
| +3% | +$33.1M | 0.32% | 69 |
|
|
2015
Q4 | $1.18B | Sell |
14,061,732
-601,262
| -4% | -$49.9M | 0.36% | 57 |
|
|
2015
Q3 | $1.23B | Sell |
14,662,994
-1,023,934
| -7% | -$86.4M | 0.38% | 56 |
|
|
2015
Q2 | $1.31B | Sell |
15,686,928
-841,464
| -5% | -$64.1M | 0.36% | 59 |
|
|
2015
Q1 | $1.2B | Buy |
16,528,392
+1,516,868
| +10% | +$108M | 0.31% | 69 |
|
|
2014
Q4 | $1.04B | Buy |
15,011,524
+2,417,542
| +19% | +$163M | 0.27% | 80 |
|
|
2014
Q3 | $817M | Buy |
12,593,982
+474,385
| +4% | +$30M | 0.22% | 97 |
|
|
2014
Q2 | $753M | Sell |
12,119,597
-1,225,445
| -9% | -$73.1M | 0.2% | 99 |
|
|
2014
Q1 | $785M | Sell |
13,345,042
-90,688
| -0.7% | -$5.06M | 0.21% | 92 |
|
|
2013
Q4 | $685M | Sell |
13,435,730
-2,247,374
| -14% | -$113M | 0.19% | 106 |
|
|
2013
Q3 | $789M | Sell |
15,683,104
-765,314
| -5% | -$40.1M | 0.23% | 87 |
|
|
2013
Q2 | $808M | Buy |
+16,448,418
| New | +$895M | 0.25% | 81 |
|
Other funds holding LLY
Bank of New York Mellon's LLY Position: Q2 2026 in Review
Bank of New York Mellon reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $78.6M and leaving 4,783,459 shares worth $5.74B. The position accounts for 0.94% of the portfolio, ranked #14.
Bank of New York Mellon first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.96B in Q2 2024. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bank of New York Mellon held 4,783,459 shares of Eli Lilly worth $5.74B as of Q2 2026.
- Bank of New York Mellon sold 76,949 Eli Lilly shares in Q2 2026, an estimated $78.6M.
- Eli Lilly made up 0.94% of Bank of New York Mellon's portfolio in Q2 2026, its #14 holding.
- Bank of New York Mellon first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Eli Lilly position peaked at $5.96B in Q2 2024.
- 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.